Eliava, M.; Melchior, M.; Knobloch-Bollmann, H. S.; Wahis, J.; da Gouveia, M. S.; Tang, Y.; Ciobanu, A. C.; Rio, R. T. d.; Roth, L. C.; Althammer, F.et al.; Chavant, V.; Goumon, Y.; Gruber, T.; Petit-Demoulière, N.; Busnelli, M.; Chini, B.; Tan, L. L.; Mitre, M.; Froemke, R. C.; Chao, M. V.; Giese, G.; Sprengel, R.; Kuner, R.; Poisbeau, P.; Seeburg, P. H.; Stoop, R.; Charlet, A.; Grinevich, V.:
A new population of parvocellular oxytocin neurons controlling magnocellular neuron activity and inflammatory pain processing.
At the MPI for Medical Research, physicists, chemists and biologists create knowledge of long-term relevance to basic medical science. With the arrival of three new directors in 2015/16, the institute has a new unifying theme: observing and controlling the vastly complex macromolecular interactions in the context of cells - both in health and disease. The presently four departments contribute to this goal through their complementary expertise: optical microscopy with nanometer resolution (Stefan Hell), the design of chemical reporter molecules (Kai Johnsson), macromolecular structure determination (Ilme Schlichting), cellular, materials and biophysical sciences (Joachim Spatz). The institute has a distinguished history of fundamental breakthroughs, evidenced by six Nobel Prizes awarded to its researchers since its foundation.